Upgrade to SI Premium - Free Trial

BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $85 at BofA Securities

March 11, 2026 5:18 AM
BofA Securities analyst Geoff Meacham lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $85.00 (from $97.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change